HGEN Lenzilumab Four Manufacturing partners have a combined market cap of $275 B - Ajinomoto Bio-Pharma, Catalent, Lonza, and Thermo Fisher- intellectual property transfer already happened - loaded for EUA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.